Featured news
-
Prospective study into controversial brain cyst syndrome is world first
The world’s first study of its kind highlights the potential value of surgery to treat a specific kind of brain cyst that blights the lives of patients.
-
How YOU can save up to nine lives
Organ Donation Week Starts today (22 to 28 September) and to mark it we share below the incredible stories of two of our patients, Debbie Montford and Jackie Little.
-
You Made a Difference - Kat Hymers
Our latest You Made a Difference award goes to Kat Hymers, Employee Relations Manager, whose professionalism, empathy and dedication have made a lasting impact on both colleagues and the wider Trust.
-
Trust eye expert welcomes green light for sight saving drug
An Addenbrooke’s consultant who has dedicated over two decades researching an incurable hereditary eye condition has welcomed approval of a treatment by a health body.
-
Trust movement surgical hub gains national accreditation
An Addenbrooke’s hospital service, which was opened in November 2023 to cut waiting times for those needing routine orthopaedic and spine operations, has won a coveted award.
-
CUH appoints independent organisation to lead patient involvement in orthopaedic review
Cambridge University Hospitals NHS Foundation Trust (CUH) has appointed Olovus, an independent specialist patient and public involvement organisation, to lead engagement with patients and families affected by the independent review into orthopaedic care provided by Ms Stohr at Addenbrooke’s Hospital.
All news
Showing 20 results
Cambridge study to trial widely used drug to protect healthcare staff from COVID-19
The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.
Medic goes from researching viruses to fighting them in the battle against COVID-19
Medic Ricky Sinharay has gone from researching viruses at the University of Cambridge, to actively fighting them – after taking up a volunteer post caring for COVID-19 patients.
National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched led by clinicians and scientists in Cambridge, and at King’s College London.
Cambridge IVF leads way to restart fertility services
Cambridge IVF has become one of the first clinics in the country to be given the green light to fully restart fertility services – to the huge relief of patients.
Board of directors' meeting - 13 May 2020
Notes from the board of director's meeting held on 13 May 2020.
Consultant helps with COVID communications
A consultant working in A&E during the COVID-19 crisis has come up with a novel way of helping staff wearing personal protective equipment (PPE) identify themselves to patients.
Hospital consultants elected to prestigious academy
Two consultants at Cambridge University Hospitals NHS Foundation Trust have been elected to a prestigious academic body, it was announced today (Wed 13 May).
Cambridge doctor’s ground-breaking app gives ventilated COVID-19 patients a voice
A ground-breaking new iPad app for ICU patients - trialed at Addenbrooke's Hospital, Cambridge - is transforming the experiences and wellbeing of critically ill COVID-19 patients in the intensive care unit (ICU).
Over 150 participants recruited to new COVID-19 research programme
A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.
Cambridge University graduates help hospital prep for pandemic
Graduates from the University of Cambridge have been combining their skills with the latest simulation software to help Addenbrooke’s predict what resources – such as oxygen, ventilators and beds – it needs to get through the COVID crisis.
Testing suggests 3% of NHS hospital staff may be unknowingly infected with coronavirus
Hospital staff are carrying SARS-CoV-2, the coronavirus that causes COVID-19 disease, without realising they are infected, according to a study by researchers at the University of Cambridge.
Genetic analysis reveals new causes of Primary Immunodeficiency (PID)
A collaboration with NIHR has combined whole genome sequencing with a statistical program to predict the existence of disease-causing changes in the DNA of people with primary immunodeficiency.
Two schoolboys treated at Addenbrooke’s Hospital for cancer teach their family and friends how to cope with isolation during the coronavirus lockdown
Best buddies Oliver Doughty and Lucas Newton, both aged 12, were forced apart by cancer because their chemotherapy treatment left them prone to infection.
New ways of working help keep critically ill patients in touch with families
Staff from Addenbrooke’s hospital are taking innovative steps to help critically ill patients stay in touch with their loved ones during the coronavirus crisis.
COVID-19 survivor says he owes his life to staff at Addenbrooke’s
A plumber from Doddington says he owes his life to staff at Addenbrooke’s after nearly dying from COVID-19.
Hospital launches hunt for scrubs super-heroes
Cambridge University Hospitals NHS Foundation Trust has launched an appeal for scrubs to help supplement existing supplies.
Research staff begin working on new COVID-19 study
Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a research trial into COVID-19.
Adapted care for cancer patients due to COVID-19
The Cancer Research UK Cambridge Centre and six other leading European cancer centres share knowledge and experiences to define new guidelines for treating cancer patients during the COVID-19 pandemic.
Patients and visitors Finding us Services For health professionals Infection control Have your say Working for us Accessibility Contact us Cambridge researchers develop new coronavirus test for frontline NHS workers at Addenbrooke’s
A new test for infection with SARS-CoV2 that which inactivates the virus at the point of sampling, has been developed by a team of researchers at the Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID).
Cambridge engineers use industrial modelling techniques to help Addenbrooke’s Hospital manage COVID-19 care
Modelling tools originally designed to improve the efficiency of factories are being used by Cambridge engineers to help Addenbrooke’s Hospital manage the COVID-19 emergency.